Study on the dynamics of antibody titer after SARS-CoV2 vaccination in patients with hematological tumors
Not Applicable
- Conditions
- Hematological malignancies
- Registration Number
- JPRN-UMIN000046573
- Lead Sponsor
- Kameda Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 544
Inclusion Criteria
Not provided
Exclusion Criteria
1) If the researcher cannot obtain written consent for participation in the research from an individual or a substitute, 2) If an individual is under 20 years of age, or 3) If the principal investigator and subcontractors determine that an individual is ineligible for the research.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Antibody titer measured at each time point in the case group
- Secondary Outcome Measures
Name Time Method